Altamira Therapeutics (NASDAQ:CYTO – Get Free Report) will be issuing its quarterly earnings results before the market opens on Tuesday, September 24th.
Altamira Therapeutics Price Performance
CYTO stock traded down $0.04 during midday trading on Friday, hitting $0.71. 53,763 shares of the company’s stock were exchanged, compared to its average volume of 895,984. The firm has a 50 day moving average price of $1.00 and a 200-day moving average price of $1.39. Altamira Therapeutics has a 12-month low of $0.71 and a 12-month high of $17.20.
Altamira Therapeutics Company Profile
Read More
- Five stocks we like better than Altamira Therapeutics
- How to Invest in Small Cap Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- High Flyers: 3 Natural Gas Stocks for March 2022
- MarketBeat Week in Review – 9/16 – 9/20
- Why Invest in 5G? How to Invest in 5G Stocks
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Altamira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altamira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.